ArticleBMC pediatrics2026
Behind the splenomegaly: a parasitic twist in siblings with beta thalassemia trait.
Article in BMC pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThalassemia syndromes are characterized by varying degrees of ineffective hematopoiesis and increased hemolysis. β-thalassemia trait typically presents as mild microcytic anemia and rarely with significant clinical findings such as splenomegaly. However, coexisting conditions in patients from endemic regions can obscure or complicate the clinical picture. Schistosomiasis, a parasitic infection endemic to Sub-Saharan Africa, is a well-recognized cause of splenomegaly and eosinophilia. CASE PRESENTATION: A pair of Congolese siblings with β-thalassemia trait presented with moderate splenomegaly and ultimately diagnosed with schistosomiasis. A 13-year-old female and a 15-year-old male, recently immigrated from a Tanzanian refugee camp, were found to have microcytic anemia, peripheral eosinophilia, and moderate splenomegaly on mandatory screening. Consultation with infectious diseases and hematology specialists led to a diagnostic evaluation that revealed positive Schistosoma species IgG antibodies. Other infectious and hematologic causes of splenomegaly were excluded. Both patients were treated with praziquantel, resulting in the resolution of eosinophilia and normalization of spleen size on physical examination within 12 months.
conclusionsThis case underscores the importance of avoiding diagnostic anchoring and highlights the need for a thorough evaluation when findings deviate from the expected clinical course.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.